All In Biotech

Drug Trial Radar · NCT03198728

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)

Last checked: Nov 19, 2026Latest source record: Jun 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 314 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

314

Actual

Start

Jul 5, 2017

Primary completion

May 1, 2020

Study completion May 1, 2020

Sponsor

Lead sponsor
Marius PharmaceuticalsIndustry
Sponsor type
Industry
Collaborators
Syneos Health
First posted
Jun 26, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This will be a randomized, multicenter, open-label, active-controlled, efficacy, and safety study in adult hypogonadal men. The study duration is 12 months (365 days), including a 90-day, open-label efficacy period and a 9-month (275-day) safety evaluation period.

Conditions

  • Hypogonadism, Male

Interventions

  • SOV2012-F1Drug

    oral preparation of testosterone undecanoate (TU)

  • AndroGelDrug

    topical testosterone gel 1.62%

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Male Hypogonadal Subjects With Average NaF/EDTA Plasma Total Testosterone (T Cavg) Within the Normal Range Using Oral SOV2012-F1.Time frame: 90 days

Locations

36 sites in 1 country. Site status is shown where the registry gives one.

  • Central Research Associates, Inc.

    Birmingham, Alabama

  • Alabama Clinical Therapeutics, LLC

    Birmingham, Alabama

  • Coastal Clinical Research, Inc.

    Mobile, Alabama

  • Quality of Life Medical and Research Centers, LLC

    Tucson, Arizona

  • San Diego Sexual Medicine

    San Diego, California

  • South Florida Medical Research

    Aventura, Florida

  • PAB Clinical Research

    Brandon, Florida

  • Innovative Research of West Florida, Inc.

    Clearwater, Florida

  • Jacksonville Impotence Treatment Center

    Jacksonville, Florida

  • Health Awareness, Inc.

    Jupiter, Florida

  • Meridien Research

    Lakeland, Florida

  • My Community Research Center

    Miami, Florida

  • Oviedo Medical Research, LLC

    Oviedo, Florida

  • Meridien Research

    St. Petersburg, Florida

  • Primary Care Research Group

    Atlanta, Georgia

  • Northwest Clinical Trials

    Boise, Idaho

  • Advanced Clinical Research

    Meridian, Idaho

  • Central Kentucky Research Associates

    Lexington, Kentucky

  • Centex Studies, Inc.

    Lake Charles, Louisiana

  • Men's Health Boston

    Chestnut Hill, Massachusetts

  • Quality Clinical Research, Inc.

    Omaha, Nebraska

  • Palm Research Center, Inc.

    Las Vegas, Nevada

  • Accumed Research Associates

    Garden City, New York

  • Manhattan Medical Research Practice, PLLC

    New York, New York

  • Rapha Institute For Clinical Research

    Fayetteville, North Carolina

  • Aventiv Research, Inc.

    Columbus, Ohio

  • Urologic Consultants of SE Pennsylvania

    Bala-Cynwyd, Pennsylvania

  • Coastal Carolina Research Center

    Mt. Pleasant, South Carolina

  • University Diabetes Endocrine Consultants

    Chattanooga, Tennessee

  • Centex Studies, Inc.

    Houston, Texas

  • Pioneer Research Solutions, Inc.

    Houston, Texas

  • Advanced Clinical Research

    West Jordan, Utah

  • Clinical Research Associates of Tidewater

    Norfolk, Virginia

  • National Clinical Research, Inc.

    Richmond, Virginia

  • Rainier Clinical Research Center, Inc.

    Renton, Washington

  • Mid-Columbia Research

    Richland, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.